...
首页> 外文期刊>Kidney International Reports >SAT-010 PROTECTIVE EFFECTS OF SPARSENTAN FROM PROLIFERATIVE GLOMERULAR INJURY INDUCED BY ADMINISTRATION OF HUMAN IMMUNE COMPLEXES IN A MURINE MODEL OF EXPERIMENTAL IgA NEPHROPATHY
【24h】

SAT-010 PROTECTIVE EFFECTS OF SPARSENTAN FROM PROLIFERATIVE GLOMERULAR INJURY INDUCED BY ADMINISTRATION OF HUMAN IMMUNE COMPLEXES IN A MURINE MODEL OF EXPERIMENTAL IgA NEPHROPATHY

机译:实验性IgA肾病小鼠模型中SAT-010对管理人免疫复合物引起的增殖性肾小球损伤所致的斯帕森坦的保护作用

获取原文

摘要

Bioinformatics analyses were performed to identify and rank the bio- markers based on their sensitivity and specificity. expression in MN serum when compared to controls (see table 1). Mx1, a GTPase commonly involved downstream of the type I IFN pathway and associated with antiviral activity, has been found to be upregulated in lupus nephritis and its association with MN warrants further investigation. The presence of EEFIG in MN patients correlate to MN murine mice model studies that have shown dif- ferential expression of EEFIG, specifically subunit alpha, in MN kidney tissue when compared with normal kidneys. GSK3B, which has been found to be associated with diabetic nephropathy through microRNA and haplotype association studies, was prominently elevated in MN patients with diabetes versus diabetes alone and may be useful in the stratification between membranous nephropathy and diabetic nephropathy. Conclusions: From this pilot study, we have found a panel of potential candidate proteins that can be further studied in a larger scale protein profiling study which can eventually lead to the discovery of more specific biomarkers which can act as a management adjunct by accu- rately diagnosing, prognosticating and aid in treatment of MN.
机译:进行了生物信息学分析,以根据其敏感性和特异性对生物标志物进行鉴定和排名。与对照组相比,MN血清中的mRNA表达(见表1)。 Mx1是一种通常参与I型IFN途径下游并与抗病毒活性相关的GTP酶,在狼疮性肾炎中已被上调,其与MN的关联值得进一步研究。 MN患者中EEFIG的存在与MN小鼠模型研究相关,该模型研究显示,与正常肾脏相比,EEFIG在MN肾脏组织中的表达有所不同,尤其是亚基α。已通过microRNA和单倍型关联研究发现与糖尿病肾病相关的GSK3B在MN糖尿病患者与单独的糖尿病患者中显着升高,可能在膜性肾病和糖尿病肾病之间的分层中有用。结论:从该初步研究中,我们发现了一组潜在的候选蛋白质,可以在大规模蛋白质谱研究中进行进一步研究,最终可以导致发现更具体的生物标志物,这些标志物可以准确地充当管理辅助剂。 MN的诊断,预后和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号